• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH CREATININE; ALKALINE PICRATE, COLORIMETRY, CREATININE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH CREATININE; ALKALINE PICRATE, COLORIMETRY, CREATININE Back to Search Results
Model Number 3L81-33
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/04/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
All available patient information was included.Additional patient details are not available.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event or Problem Description
The customer reported a falsely elevated creatinine result on one patient sample when running on the architect c16000 processing module.The following data was provided: initial creatinine result = 7.61 mg/dl; repeat on another analyzer = 0.78 mg/dl; repeat on the first analyzer = 0.75 mg/dl there was no impact to patient management reported.
 
Event or Problem Description
The customer reported a falsely elevated creatinine result on one patient sample when running on the architect c16000 processing module.The following data was provided: initial creatinine result = 7.61 mg/dl; repeat on another analyzer = 0.78 mg/dl; repeat on the first analyzer = 0.75 mg/dl there was no impact to patient management reported.
 
Additional Manufacturer Narrative
Customer returns were not available.Trending review determined no trend for the issue for the product.Historical complaint review determined there is normal complaint activity for the lot number.Device history record review did not show any potential non-conformances, or deviations.Labeling was reviewed and found to adequately address the issue under review.Historical performance of reagent lot 09280un22 was evaluated using world-wide data from abbottlink.The patient data was analyzed and compared to an established control limit.This evaluation indicated that the patient median result for lot 09280un22 is within the established control limits.Based on the investigation, no deficiency for lot number 09280un22 was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CREATININE
Common Device Name
ALKALINE PICRATE, COLORIMETRY, CREATININE
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
siobhan wright
lisnamuck
post market surveillance
longford N39 E-932
EI   N39 E932
433331157
MDR Report Key16890854
Report Number3002809144-2023-00226
Device Sequence Number20411213
Product Code CGX
UDI-Device Identifier00380740161569
UDI-Public00380740161569
Combination Product (Y/N)N
Initial Reporter CountrySP
PMA/510(K) Number
K083809
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 06/29/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/12/2023
Device Model Number3L81-33
Device Catalogue Number03L81-33
Device Lot Number09280UN22
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 05/04/2023
Supplement Date Received by Manufacturer06/27/2023
Initial Report FDA Received Date05/08/2023
Supplement Report FDA Received Date06/29/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured02/21/2022
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ARC C16K PRC MOD, 03L77-01, C1601213; ARC C16K PRC MOD, 03L77-01, C1601213
Patient SexUnknown
-
-